Get startedLog in
    Picture of Alligator Bioscience AB logo

    ATORX — Alligator Bioscience AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Alligator Bioscience Announces Positive Interim Results From Phase 2 Trial

    Picture of Alligator Bioscience AB logoAlligator Bioscience AB
    03/01/2023 07:01
    Jan 3 (Reuters) - Alligator Bioscience AB  ATORX.ST :
    * SAID ON MONDAY, ALLIGATOR BIOSCIENCE ANNOUNCES POSITIVE
INTERIM
RESULTS FROM MITAZALIMAB OPTIMIZE-1 PHASE 2 TRIAL IN PANCREATIC
CANCER   
    * INTERIM RESULTS DEMONSTRATE OBJECTIVE RESPONSE RATE OF 52%
IN 23
EVALUABLE PATIENTS

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nMFN1XxJZB
 Further company coverage:  ATORX.ST  
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Alligator Bioscience AB

    See all news